Page last updated: 2024-08-03 08:25:45
triazacyclononane
Description
triazacyclononane: structure in first source [MeSH]
Cross-References
ID Source | ID |
PubMed CID | 21896526 |
SCHEMBL ID | 22648 |
MeSH ID | M0462675 |
Synonyms (2)
Synonym |
SCHEMBL22648 |
triazacyclononane |
Research
Studies (39)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 12 (30.77) | 29.6817 |
2010's | 25 (64.10) | 24.3611 |
2020's | 2 (5.13) | 2.80 |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 39 (100.00%) | 84.16% |
Substance | Studies | Classes | Roles | First Year | Last Year | Average Age | Relationship Strength | Trials | pre-1990 | 1990's | 2000's | 2010's | post-2020 |
carbon monoxide | | carbon oxide; gas molecular entity; one-carbon compound | biomarker; EC 1.9.3.1 (cytochrome c oxidase) inhibitor; human metabolite; ligand; metabolite; mitochondrial respiratory-chain inhibitor; mouse metabolite; neurotoxin; neurotransmitter; P450 inhibitor; probe; signalling molecule; vasodilator agent | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
citric acid, anhydrous | | tricarboxylic acid | antimicrobial agent; chelator; food acidity regulator; fundamental metabolite | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
1-aminocyclopropane-1-carboxylic acid | | amino acid zwitterion; monocarboxylic acid; non-proteinogenic alpha-amino acid | ethylene releasers; plant metabolite | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
glycerol | | alditol; triol | algal metabolite; detergent; Escherichia coli metabolite; geroprotector; human metabolite; mouse metabolite; osmolyte; Saccharomyces cerevisiae metabolite; solvent | 2015 | 2015 | 9.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
hydrogen carbonate | | carbon oxoanion | cofactor; Escherichia coli metabolite; human metabolite; mouse metabolite; Saccharomyces cerevisiae metabolite | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
nickel | | metal allergen; nickel group element atom | epitope; micronutrient | 2022 | 2022 | 2.0 | low | 0 | 0 | 0 | 0 | 0 | 1 |
picolinic acid | | pyridinemonocarboxylic acid | human metabolite; MALDI matrix material | 2013 | 2013 | 11.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2,2'-dipyridyl | | bipyridine | chelator; ferroptosis inhibitor | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
2,4-dinitrophenol | | dinitrophenol | allergen; antiseptic drug; bacterial xenobiotic metabolite; geroprotector; oxidative phosphorylation inhibitor | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
aluminum fluoride | | aluminium coordination entity | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
4-cresol | | cresol | Escherichia coli metabolite; human metabolite; uremic toxin | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
ethidium | | phenanthridines | fluorochrome; intercalator | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
phenylalanine | | amino acid zwitterion; erythrose 4-phosphate/phosphoenolpyruvate family amino acid; L-alpha-amino acid; phenylalanine; proteinogenic amino acid | algal metabolite; EC 3.1.3.1 (alkaline phosphatase) inhibitor; Escherichia coli metabolite; human xenobiotic metabolite; micronutrient; mouse metabolite; nutraceutical; plant metabolite; Saccharomyces cerevisiae metabolite | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
histidine | | amino acid zwitterion; histidine; L-alpha-amino acid; polar amino acid zwitterion; proteinogenic amino acid | algal metabolite; Escherichia coli metabolite; human metabolite; micronutrient; mouse metabolite; nutraceutical; Saccharomyces cerevisiae metabolite | 2009 | 2022 | 8.7 | low | 0 | 0 | 0 | 1 | 1 | 1 |
ethylene | | alkene; gas molecular entity | plant hormone; refrigerant | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
diethylenetriamine | | polyazaalkane; triamine | | 2009 | 2009 | 15.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
2,6-xylenol | | hydroxytoluene | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
2,2'-dipyridylamine | | | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
manganese | | elemental manganese; manganese group element atom | Escherichia coli metabolite; micronutrient | 2007 | 2013 | 14.0 | low | 0 | 0 | 0 | 1 | 1 | 0 |
terbium | | f-block element atom; lanthanoid atom | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
cadmium | | cadmium molecular entity; zinc group element atom | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
europium | | f-block element atom; lanthanoid atom | | 2013 | 2014 | 10.3 | low | 0 | 0 | 0 | 0 | 3 | 0 |
gadolinium | | f-block element atom; lanthanoid atom | | 2007 | 2007 | 17.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
gold | | copper group element atom; elemental gold | | 2012 | 2019 | 8.5 | low | 0 | 0 | 0 | 0 | 2 | 0 |
uranium | | actinoid atom; f-block element atom; monoatomic uranium | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
salen | | | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
fluorides | | halide anion; monoatomic fluorine | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
phenyl acetate | | benzenes; phenyl acetates | | 2011 | 2011 | 13.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
transferrin | | | | 2016 | 2016 | 8.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
cyclen | | azacycloalkane; crown amine; saturated organic heteromonocyclic parent | | 2018 | 2022 | 4.0 | low | 0 | 0 | 0 | 0 | 1 | 1 |
edotreotide | | | | 2008 | 2008 | 16.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
1,4,7-triazacyclononane | | azacycloalkane; crown amine; saturated organic heteromonocyclic parent | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
1,4,7-trimethyl-1,4,7-triazacyclononane | | | | 2010 | 2010 | 14.0 | low | 0 | 0 | 0 | 1 | 0 | 0 |
glycyllysine | | dipeptide | metabolite | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
lysylglycine | | dipeptide | metabolite | 2018 | 2018 | 6.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
piperidines | | | | 2003 | 2022 | 11.5 | high | 0 | 0 | 0 | 13 | 24 | 1 |
amyloid beta-peptides | | | | 2014 | 2014 | 10.0 | low | 0 | 0 | 0 | 0 | 1 | 0 |
Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy.Chemistry (Weinheim an der Bergstrasse, Germany), , Jan-12, Volume: 24, Issue:3, 2018
Transferrin conjugates of triazacyclononane-based bifunctional NE3TA chelates for PET imaging: Synthesis, Cu-64 radiolabeling, and in vitro and in vivo evaluation.Journal of inorganic biochemistry, , Volume: 154, 2016
Dual-Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy.Chemistry (Weinheim an der Bergstrasse, Germany), , Jan-12, Volume: 24, Issue:3, 2018
Transferrin conjugates of triazacyclononane-based bifunctional NE3TA chelates for PET imaging: Synthesis, Cu-64 radiolabeling, and in vitro and in vivo evaluation.Journal of inorganic biochemistry, , Volume: 154, 2016